Malignant lymphoma of the central nervous system with delayed increased accumulation on I-123 IMP SPECT.

Abstract

Ga-67 citrate scintigraphy in the management of malignant lymphomas is well established. It cannot, however, differentiate malignant from benign lesions because this agent also accumulates in benign inflammatory lesions. The authors present a case of increased I-123 IMP uptake on both early and delayed SPECT images in a patient with malignant lymphoma of the central nervous system. Results show that I-123 IMP SPECT can help differentiate malignant lymphoma from benign lesions and other malignant brain tumors.

• Authors: Y Yamamoto, Y Nishiyama, K Kawakita, Y Toyama, M Ohkawa, M Tanabe
• Journal: Clinical nuclear medicine (Clin Nucl Med) Vol. 26 Issue 2 Pg. 105-8 (Feb 2001) ISSN: 0363-9762 [Print] United States
• PMID: 11201464 (Publication Type: Case Reports, Journal Article)

Chemical References

• Gallium Radioisotopes
• Radiopharmaceuticals
• Iofetamine

Topics

• Aged
• Central Nervous System Neoplasms (diagnostic imaging, pathology)
• Female
• Gallium Radioisotopes
• Gamma Cameras
• Humans
• Iofetamine
• Lymphoma, B-Cell (diagnostic imaging, pathology)
• Paresis (etiology)
• Radiopharmaceuticals
• Tomography, Emission-Computed, Single-Photon